ROUTE    CONTACT
zoeken
FOLLOW US:
Our team
Our team
Dominique de Kleijn - Chief Technology Officer (CTO)
Dominique de Kleijn, PhD, is a Professor of the Experimental Cardiology Laboratory at UMCU and co-initiator of the Athero-Express Biobank Studies. Dominique is project leader of the Interuniversity Cardiology Institute of the Netherlands (ICIN). As a molecular biologist with a BSc in chemistry he performed the proteomics studies of the Athero-Express. His research focus (>100 papers) is the role of the innate immune system in the response to injury during atherogenesis and after myocardial infarction.
Bookmark and Share
Related items
Our mission
CAVΛDIS™ is a Dutch biomedical company active in the field of cardiovascular risk assessment. The company's mission is to identify patients at risk of developing heart attacks and strokes. Our ultimate goal is to develop clinically meaningful risk stratification tools that will help personalize treatment and achieve better patient outcomes.
read more